Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

ClinicalTrials.gov ID: NCT00090779

Public ClinicalTrials.gov record NCT00090779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 5:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The SETPOINT Study - A Randomized Study of the Effect of Immediate Treatment With Potent Antiretroviral Therapy Versus Observation With Treatment as Indicated in Newly Infected HIV-1 Infected Subjects: Does Early Therapy After the Virologic Setpoint?

Study identification

NCT ID
NCT00090779
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Network
Enrollment
130 participants

Conditions and interventions

Conditions

Interventions

  • Emtricitabine/ tenofovir disoproxil fumarate Drug
  • Lopinavir/Ritonavir Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2004
Primary completion
Jun 30, 2009
Completion
Apr 30, 2011
Last update posted
Oct 10, 2018

2005 – 2011

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Ucsd, Avrc Crs (701) San Diego California 92103
Ucsf Aids Crs (801) San Francisco California 94110
Harbor-UCLA Med. Ctr. CRS (603) Torrance California 90502
University of Colorado Hospital CRS (6101) Aurora Colorado 80045
University of Miami AIDS CRS (901) Miami Florida 33139
The Ponce de Leon Center CRS Atlanta Georgia 30308
Northwestern University CRS (2701) Chicago Illinois 60611
Rush Univ. Med. Ctr. ACTG CRS (2702) Chicago Illinois 60612
Indiana University Hospital (2601) Indianapolis Indiana 46202-5250
IHV Baltimore Treatment CRS (4651) Baltimore Maryland 21201
Massachusetts General Hospital ACTG CRS (101) Boston Massachusetts 02114
Brigham and Women's Hosp. ACTG CRS (107) Boston Massachusetts 02115
Washington University CRS (2101) St Louis Missouri 63110
Beth Israel Medical Center New York New York 10003
HIV Prevention & Treatment CRS (30329) New York New York 10032
AIDS Care CRS (1108) Rochester New York 14642
University of Rochester ACTG CRS (1101) Rochester New York 14642
Unc Aids Crs (3201) Chapel Hill North Carolina 27516
Moses H. Cone Memorial Hospital CRS (3203) Greensboro North Carolina 27401
Regional Center for Infectious Disease, Wendover Medical Center CRS (3203) Greensboro North Carolina 27401
The Ohio State Univ. AIDS CRS (2301) Columbus Ohio 43210
Hosp. of the Univ. of Pennsylvania CRS (6201) Philadelphia Pennsylvania 19104
The Miriam Hosp. ACTG CRS (2951) Providence Rhode Island 02906
University of Washington AIDS CRS (1401) Seattle Washington 98104
UW Primary Infection Clinic CRS (1404) Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00090779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 10, 2018 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00090779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →